Myasthenia Gravis: Passive Transfer from Man to Mouse
- 24 October 1975
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 190 (4212), 397-399
- https://doi.org/10.1126/science.1179220
Abstract
Daily injections into mice of an ammonium sulfate-precipitated immunoglobulin fraction of serum from patients with myasthenia gravis were carried out for up to 14 days. The mice showed reduced amplitudes of miniature endplate potentials and reduced numbers of acetylcholine receptors at the neuromuscular junctions. Some mice showed typical decremental responses on repetitive nerve stimulation, with reversal by neostigmine. This represents the first evidence of a circulating factor in the serum of patients with myasthenia gravis which on passive transfer reproduces features of the disease in experimental animals.Keywords
This publication has 14 references indexed in Scilit:
- Blockade of Acetylcholine Receptors: A Model of Myasthenia GravisScience, 1975
- MYASTHENIA GRAVIS: A SERUM FACTOR BLOCKING ACETYLCHOLINE RECEPTORS OF THE HUMAN NEUROMUSCULAR JUNCTIONThe Lancet, 1975
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine ReceptorsScience, 1974
- Acetylcholine ReceptorsThe Journal of general physiology, 1974
- Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine ReceptorsScience, 1973
- Autoimmune Response to Acetylcholine ReceptorScience, 1973
- ELECTRICAL TESTING IN MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1971
- FURTHER STUDIES ON THE SPECIFICITY OF PRESUMED IMMUNE ASSOCIATIONS OF MYASTHENIA GRAVIS AND CONSIDERATION OF POSSIBLE PATHOGENIC IMPLICATIONSAnnals of the New York Academy of Sciences, 1966
- FACTORS CONTROLLING SERUM γ-GLOBULIN CONCENTRATIONThe Journal of Experimental Medicine, 1963
- Determination of Thiocyanate in Blood SerumScandinavian Journal of Clinical and Laboratory Investigation, 1953